Clinical Trial Update: A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CYP-001 in combination with corticosteroids for adults with high-risk acute graft-versus-host disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYP-001

Snippet

Sponsor: Cynata Therapeutics Limited | Conditions: Graft Versus Host Disease, Acute | Phase 2 | Status: RECRUITING